
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial
Nasser K. Altorki, Zachary Walsh, Johannes C. Melms, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Nasser K. Altorki, Zachary Walsh, Johannes C. Melms, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Showing 16 citing articles:
Micronuclei induced by radiation, replication stress, or chromosome segregation errors do not activate cGAS-STING
Tohru Takaki, Rhona Millar, Crispin T. Hiley, et al.
Molecular Cell (2024) Vol. 84, Iss. 11, pp. 2203-2213.e5
Open Access | Times Cited: 19
Tohru Takaki, Rhona Millar, Crispin T. Hiley, et al.
Molecular Cell (2024) Vol. 84, Iss. 11, pp. 2203-2213.e5
Open Access | Times Cited: 19
Radiotherapy and immunology
Liangliang Wang, Connor Lynch, Sean P. Pitroda, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 7
Open Access | Times Cited: 18
Liangliang Wang, Connor Lynch, Sean P. Pitroda, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 7
Open Access | Times Cited: 18
Next-generation combination approaches for immune checkpoint therapy
Sangeeta Goswami, Kristen E. Pauken, Linghua Wang, et al.
Nature Immunology (2024) Vol. 25, Iss. 12, pp. 2186-2199
Closed Access | Times Cited: 6
Sangeeta Goswami, Kristen E. Pauken, Linghua Wang, et al.
Nature Immunology (2024) Vol. 25, Iss. 12, pp. 2186-2199
Closed Access | Times Cited: 6
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial
Ze-Rui Zhao, Shiliang Liu, Ting Zhou, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 12, pp. 988-996
Closed Access | Times Cited: 4
Ze-Rui Zhao, Shiliang Liu, Ting Zhou, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 12, pp. 988-996
Closed Access | Times Cited: 4
Lung Cancer Research and Treatment: Global Perspectives and Strategic Calls to Action
May-Lucie Meyer, S. Peters, Tony Mok, et al.
Annals of Oncology (2024)
Closed Access | Times Cited: 4
May-Lucie Meyer, S. Peters, Tony Mok, et al.
Annals of Oncology (2024)
Closed Access | Times Cited: 4
Recent Mechanistic Insight into the Immunogenic Properties of Radiation-Induced Micronuclei
Claire Vanpouille‐Box
International Journal of Radiation Oncology*Biology*Physics (2025) Vol. 121, Iss. 2, pp. 283-286
Closed Access
Claire Vanpouille‐Box
International Journal of Radiation Oncology*Biology*Physics (2025) Vol. 121, Iss. 2, pp. 283-286
Closed Access
Immunotherapy for early-stage non-small cell lung cancer: A practical guide of current controversies
William J. Phillips, Ashley Jackson, Biniam Kidane, et al.
Clinical Lung Cancer (2025)
Open Access
William J. Phillips, Ashley Jackson, Biniam Kidane, et al.
Clinical Lung Cancer (2025)
Open Access
Radical hemithorax radiotherapy induces an increase in circulating PD-1+ T lymphocytes and in the soluble levels of PD-L1 in malignant pleural mesothelioma patients: a possible synergy with PD-1/PD-L1 targeting treatment?
Alberto Revelant, Francesca Gessoni, Marcella Montico, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Alberto Revelant, Francesca Gessoni, Marcella Montico, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Reconciling the discrepancies in randomized data of combining immunotherapy and radiation therapy: Not all radiotherapy is created equal
Joe Y. Chang, Vivek Verma, Ralph R. Weichselbaum
European Journal of Cancer (2024) Vol. 201, pp. 113972-113972
Closed Access | Times Cited: 3
Joe Y. Chang, Vivek Verma, Ralph R. Weichselbaum
European Journal of Cancer (2024) Vol. 201, pp. 113972-113972
Closed Access | Times Cited: 3
Single-cell transcriptome analysis of low-dose radiotherapy-mediated alleviation of LPS-induced acute lung injury
Sung‐Eun Lee, Sang Hoon Seo, Yeon Joo Kim, et al.
Research Square (Research Square) (2024)
Open Access
Sung‐Eun Lee, Sang Hoon Seo, Yeon Joo Kim, et al.
Research Square (Research Square) (2024)
Open Access
Stereotactic body radiotherapy plus neoadjuvant chemoimmunotherapy in operable non-small-cell lung cancer
Rafał Dziadziuszko, Bartłomiej Tomasik
The Lancet Respiratory Medicine (2024)
Closed Access
Rafał Dziadziuszko, Bartłomiej Tomasik
The Lancet Respiratory Medicine (2024)
Closed Access
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: Long-Term Clinical Outcomes
Vivian Tan, Rohann Correa, Timothy K. Nguyen, et al.
International Journal of Radiation Oncology*Biology*Physics (2024)
Open Access
Vivian Tan, Rohann Correa, Timothy K. Nguyen, et al.
International Journal of Radiation Oncology*Biology*Physics (2024)
Open Access
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7 th immunorad conference
Pierre-Antoine Laurent, Fabrice André, Alexandre Bobard, et al.
OncoImmunology (2024) Vol. 14, Iss. 1
Open Access
Pierre-Antoine Laurent, Fabrice André, Alexandre Bobard, et al.
OncoImmunology (2024) Vol. 14, Iss. 1
Open Access
Immune checkpoint inhibition in early-stage non-small cell lung cancer
Kristof Cuppens, Bert Du Pont, J. Knegjens, et al.
Lung Cancer (2024) Vol. 193, pp. 107855-107855
Open Access
Kristof Cuppens, Bert Du Pont, J. Knegjens, et al.
Lung Cancer (2024) Vol. 193, pp. 107855-107855
Open Access
Advancing neoadjuvant therapies in resectable non-small cell lung cancer: implications for novel treatment strategies and biomarker discovery
Hyein Jeon, Rajvi Gor, Angelica D’Aiello, et al.
Pathology & Oncology Research (2024) Vol. 30
Open Access
Hyein Jeon, Rajvi Gor, Angelica D’Aiello, et al.
Pathology & Oncology Research (2024) Vol. 30
Open Access
Higher immune cell radiation dose is correlated with poor tumor control and survival in patients with non-small cell lung cancer receiving postoperative radiotherapy
Zeliang Ma, Yunsong Liu, Yongxing Bao, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Zeliang Ma, Yunsong Liu, Yongxing Bao, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Impact of mediastinal tumor burden and lymphatic spread in locally advanced non-small-cell lung cancer: A secondary analysis of the multicenter randomized PET-Plan trial
Eleni Gkika, Cas Stefaan Dejonckheere, Jörg Sahlmann, et al.
Radiotherapy and Oncology (2024) Vol. 200, pp. 110521-110521
Closed Access
Eleni Gkika, Cas Stefaan Dejonckheere, Jörg Sahlmann, et al.
Radiotherapy and Oncology (2024) Vol. 200, pp. 110521-110521
Closed Access